Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 111
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00304551 | A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) | ||
| NCT03157635 | Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria | ||
| NCT04963270 | A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis | ||
| NCT01817699 | Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients | ||
| NCT00144534 | Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP | ||
| NCT04318275 | Objective Pain Measurement Using a Wearable Biosensor and a Mobile Platform in Patients With Endometriosis | ||
| NCT02965053 | A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis | ||
| NCT05271409 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease | ||
| NCT04432584 | A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors | ||
| NCT02748837 | A Study of ERY974 in Patient With Advanced Solid Tumors | ||
| NCT00144456 | A New Active Vitamin D, ED-71 for Osteoporosis | ||
| NCT04511845 | A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion). | ||
| NCT06371417 | Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) | ||
| NCT02485483 | Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants | ||
| NCT00247663 | Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | ||
| NCT00491868 | Clinical Study of R744 to Hemodialysis Patients | ||
| NCT00492427 | Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta) | ||
| NCT02847637 | A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors | ||
| NCT04732598 | A Phase III Study of Bevacizumab and Paclitaxel in Combination with Atezolizumab As a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer | ||
| NCT05269667 | A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention | ||
| NCT05907980 | A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors | ||
| NCT05494619 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS) | ||
| NCT04846582 | An Observational Study of Patients With Endometriosis to Evaluate the Usefulness of the MEDL Score, a New Method for Evaluating Endometriosis Using MRI | ||
| NCT00144586 | Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP | ||
| NCT04861259 | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) | ||
| NCT01986933 | A Phase 2 Study of CIM331 for Atopic Dermatitis Patients | ||
| NCT00433693 | Correction Study of R744 in Renal Anemia Patients on Hemodialysis | ||
| NCT06793553 | Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC | ||
| NCT03748901 | PD-L1 Expression in Japanese Renal Cell Carcinoma Patients | ||
| NCT03645330 | A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL) | ||
| NCT00144469 | A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C | ||
| NCT00144651 | Study of MRA in Patients With Rheumatoid Arthritis (RA) | ||
| NCT05425446 | Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients | ||
| NCT00433888 | Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study) | ||
| NCT00779220 | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis | ||
| NCT06723106 | Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) | ||
| NCT02537379 | Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection | ||
| NCT04818983 | The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) | ||
| NCT03020160 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A | ||
| NCT04097444 | CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC | ||
| NCT00467012 | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer | ||
| NCT05012618 | A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion). | ||
| NCT00208260 | Intensified Chemotherapy in CRC After Resection of Liver Metastases | ||
| NCT00144495 | A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy | ||
| NCT02622321 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors | ||
| NCT00144664 | Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) | ||
| NCT05503264 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis | ||
| NCT06497556 | A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer | ||
| NCT04338269 | A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment | ||
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer |
